Artiva Biotherapeutics In... (ARTV)
7.06
0.53 (8.12%)
At close: Jan 21, 2025, 3:59 PM
7.07
0.14%
After-hours Jan 21, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -28.72M | -58.79M | -71.83M | -17.99M |
| Depreciation & Amortization | 2.27M | 1.16M | 248.00K | 73.00K |
| Stock-Based Compensation | 7.05M | 6.58M | 4.31M | 297.00K |
| Other Working Capital | -27.36M | -2.38M | 28.92M | 249.00K |
| Other Non-Cash Items | 251.00K | n/a | 18.55M | -278.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a |
| Change in Working Capital | -28.28M | -3.87M | 33.41M | 4.36M |
| Operating Cash Flow | -47.43M | -50.83M | -15.30M | -13.54M |
| Capital Expenditures | -3.26M | -6.30M | -1.72M | -284.00K |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | -49.52M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 26.80M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -25.98M | -6.30M | -1.72M | -284.00K |
| Debt Repayment | n/a | n/a | n/a | 3.00M |
| Common Stock Repurchased | -12.00K | -5.00K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 24.40M | -1.26M | 152.75M | 34.18M |
| Financial Cash Flow | 24.39M | -1.26M | 152.75M | 37.40M |
| Net Cash Flow | -49.01M | -58.39M | 135.73M | 23.57M |
| Free Cash Flow | -50.69M | -57.13M | -17.03M | -13.82M |